Structure and dynamics of thioguanine-modified duplex DNA
about
Effect of 6-thioguanine on the stability of duplex DNAStructural effect of the anticancer agent 6-thioguanine on duplex DNAThe effect of 6-thioguanine on alternative splicing and antisense-mediated exon skipping treatment for duchenne muscular dystrophyGuanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in vitro and in vivo.Use of thiopurines in inflammatory bowel disease: Safety issues.IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.Solution structure and stability of the DNA undecamer duplexes containing oxanine mismatch.In vitro replication and thermodynamic studies of methylation and oxidation modifications of 6-thioguanine.Apoptosome activation, an important molecular instigator in 6-mercaptopurine induced Leydig cell death.High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.Enhanced base pairing and replication efficiency of thiothymidines, expanded-size variants of thymidineProperties of pseudo-complementary DNA substituted with weakly pairing analogs of guanine or cytosineThiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.TPMT*26 (208F-->L), a novel mutation detected in a Chinese.Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.Immunosuppressive and biologic therapy for ulcerative colitis.The safety of treatment options for pediatric Crohn's disease.Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells.The effect of S-substitution at the O6-guanine site on the structure and dynamics of a DNA oligomer containing a G:T mismatch.Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.The DNA-forming properties of 6-selenoguanine.Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.DNA duplex stability of the thio-iso-guanine•methyl-iso-Cytosine base pair.The electronic spectra and the H-bonding pattern of the sulfur and selenium substituted guanines.The impact of 6-thioguanine incorporation into DNA on the function of DNA methyltransferase Dnmt3a.NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients.Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
P2860
Q24805824-F4538D98-2092-4176-B177-E00BCC439220Q27640490-18D7B70C-9E21-41FB-9B27-4EFA6C14C633Q28484390-E746F2BD-1146-4C54-BD74-9B5A556026FFQ33525253-78D80496-3DC8-4A80-9CD3-0939A568373EQ33621267-55B1FCD3-21A2-484F-BAA2-CDE37BB703A2Q34568904-6CFAEAA6-1F0E-420A-B068-FC43A288653DQ35780133-8D518EF0-D322-483A-A833-3D161DABE773Q35893844-E81F8146-5066-401E-87F2-5D72B3922C66Q36291554-C36FBD79-6C78-4D20-AC1A-D6CA0E8A919EQ36396288-D52896A2-4689-45DD-A19E-EAB6A1B99353Q36914344-E2DFFB8D-E77C-47DA-B0C1-29C4A74E7666Q37014656-7FD7FF9E-BC1C-4410-9216-399E55AE357CQ37087479-8A0413CB-9FD8-4B93-A4E1-0E0DE85181B0Q37199282-E0A02B7A-0F9D-4152-AEE8-B4BEEEA7BFF0Q37321444-3E11037D-B6B5-470C-82EF-24D86CA4AE10Q37345896-58DD14CA-ECA0-4F03-AA5D-524E129D9556Q37388537-5B46AF41-C24C-48ED-B032-FD4C890CBC54Q37658863-1804C398-B66A-4195-8A49-99D79A1BDD05Q38060831-2340BF43-5F8A-4A0F-8EFC-05D884858A6CQ38883237-DFABA88E-D78A-4993-A63F-0542628A2193Q39334739-ED7D5763-5483-43B5-BE70-88D844AFFD6AQ40342697-DFFA1961-2553-4558-BDB3-95FA19CF56A4Q41070453-88DA4A72-8549-489B-B105-B0B180450FB2Q44932093-366C7E1D-7AA4-4F7B-BED4-D93DD8B4E84CQ45249819-0F72B99B-735A-47E3-A989-383CCBF008DCQ45943688-56C33061-7635-4AAE-8B89-82698035DC04Q46020036-E019CDE8-4280-44B9-9BB6-819ECD3E760FQ47885520-850D9205-C26D-4BA2-96EF-DAB5CA279370Q51006571-B27D1F94-EB91-4098-B086-2F4D2F150A76Q54975027-65B26762-BF18-4845-890D-933FEC57711FQ57817595-4DEC448C-7597-4172-A543-9BEA4FF6DA8D
P2860
Structure and dynamics of thioguanine-modified duplex DNA
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Structure and dynamics of thioguanine-modified duplex DNA
@ast
Structure and dynamics of thioguanine-modified duplex DNA
@en
Structure and dynamics of thioguanine-modified duplex DNA
@nl
type
label
Structure and dynamics of thioguanine-modified duplex DNA
@ast
Structure and dynamics of thioguanine-modified duplex DNA
@en
Structure and dynamics of thioguanine-modified duplex DNA
@nl
prefLabel
Structure and dynamics of thioguanine-modified duplex DNA
@ast
Structure and dynamics of thioguanine-modified duplex DNA
@en
Structure and dynamics of thioguanine-modified duplex DNA
@nl
P2093
P2860
P356
P1476
Structure and dynamics of thioguanine-modified duplex DNA
@en
P2093
Craig A Marhefka
Eugene Y Krynetski
Lilla Somerville
Natalia F Krynetskaia
Richard D Beger
Richard W Kriwacki
Weixing Zhang
William E Evans
P2860
P304
P356
10.1074/JBC.M204243200
P407
P577
2003-01-10T00:00:00Z